SCHEMBL15944209

SCHEMBL15944209

CCCCc1nc(Cl)cn1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1

nearest known ligand 0.56

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
AGTR1 P30556 2/20 0.53
AGTR2 P50052 2/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29382524 1.00 AGTR1 (0.53) AGTR1AGTR2
SCHEMBL3320753 0.87 AGTR1 (0.51) AGTR1AGTR2
Hydrochloric Acid SCHEMBL9046797 0.86 AGTR1 (0.49) AGTR1AGTR2
Hydrochloric Acid SCHEMBL9141589 0.86 AGTR1 (0.49) AGTR1AGTR2
SCHEMBL9116560 0.86 AGTR1 (0.51) AGTR1AGTR2
SCHEMBL1974482 0.86 AGTR1 (0.49) AGTR1AGTR2
SCHEMBL9024040 0.86 AGTR1 (0.49) AGTR1AGTR2
SCHEMBL9024994 0.85
SCHEMBL9113229 0.85 AGTR1 (0.49) AGTR1AGTR2
SCHEMBL3320748 0.85 AGTR1 (0.49) AGTR1AGTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9138393-B2 Cosmetic compositions containing substituted azole and methods for improving the appearance of aging skin THE PROCTER & GAMBLE COMPANY (US) 2015-09-22 US disclosed
US-9138393-B2 Cosmetic compositions containing substituted azole and methods for improving the appearance of aging skin THE PROCTER & GAMBLE COMPANY (US) 2015-09-22 US disclosed
US-20140227206-A1 COSMETIC COMPOSITIONS CONTAINING SUBSTITUTED AZOLE AND METHODS FOR IMPROVING THE APPEARANCE OF AGING SKIN THE PROCTER & GAMBLE COMPANY (US) 2014-08-14 US disclosed
US-20140227206-A1 COSMETIC COMPOSITIONS CONTAINING SUBSTITUTED AZOLE AND METHODS FOR IMPROVING THE APPEARANCE OF AGING SKIN THE PROCTER & GAMBLE COMPANY (US) 2014-08-14 US disclosed
US-20140227208-A1 COSMETIC COMPOSITIONS CONTAINING SUBSTITUTED AZOLE AND METHODS FOR ALLEVIATING MECHANICALLY-INDUCED SKIN INFLAMMATION THE PROCTER & GAMBLE COMPANY (US) 2014-08-14 US disclosed
US-20140227208-A1 COSMETIC COMPOSITIONS CONTAINING SUBSTITUTED AZOLE AND METHODS FOR ALLEVIATING MECHANICALLY-INDUCED SKIN INFLAMMATION THE PROCTER & GAMBLE COMPANY (US) 2014-08-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140227206-A1 COSMETIC COMPOSITIONS CONTAINING SUBSTITUTED AZOLE AND METHODS FOR IMPROVING THE APPEARANCE OF AGING SKIN TYR, CUTA, HDAC4 AGTR1 4130/4885AGTR2 4418/4885
US-20140227208-A1 COSMETIC COMPOSITIONS CONTAINING SUBSTITUTED AZOLE AND METHODS FOR ALLEVIATING MECHANICALLY-INDUCED SKIN INFLAMMATION CUTA, KRT18, IL33 AGTR1 2220/4885AGTR2 2145/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.